Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Solid Tumor 2Stomach Neoplasms 1Solid Tumor Cancer 1Refractory Solid Tumors 1Pseudomyxoma Peritonei 1Neoplasms, Cystic, Mucinous, and Serous 1Mesothelioma 1Malignant Solid Neoplasm 1Colorectal Neoplasms 1Advanced Solid Tumors 1Adenocarcinoma, Mucinous 1

Interventions

irinotecan sucrosofate 1atezolizumab 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Mucinous × irinotecan sucrosofate × Other solid neoplasm × Clear all
NCT04088786 2022-05-06

Phase I Trial HIPEC With Nal-irinotecan

Stony Brook University

Phase 1 Completed
18 enrolled
GastrointestinalOther solid neoplasmThoracic

Adenocarcinoma, Mucinous, Mesothelioma, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡